Prolonged survival of a patient with pelvic recurrence of ovarian malignant mixed mullerian tumor after chemoradiotherapy

Fatemeh Homaei Shandiz; Sima Kadkhodayan; Malihe Hsanzade Mofrad; Zohre Yousefi Roodsari; Noorieh Sharifi Sistani; Majid Nabizadeh Marvast; Mahbobe Sadeghei

doi:10.5812/ircmj.14919

Prolonged survival of a patient with pelvic recurrence of ovarian malignant mixed mullerian tumor after chemoradiotherapy

Iran Red Crescent Med J. 2014 Sep 5;16(9):e14919. doi: 10.5812/ircmj.14919. eCollection 2014 Sep.

Authors

Fatemeh Homaei Shandiz¹, Sima Kadkhodayan², Malihe Hsanzade Mofrad², Zohre Yousefi Roodsari², Noorieh Sharifi Sistani¹, Majid Nabizadeh Marvast³, Mahbobe Sadeghei¹

Affiliations

¹ Research Center of Solid Tumor Treatment, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran.
² Research Center of Women's Health, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran.
³ Mashhad University of Medical Sciences, Mashhad, IR Iran.

Abstract

Introduction: Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1% of all ovarian cancers.

Case presentation: We present a 64-year-old woman with stage III MMMT of ovary that was treated with platinum-based chemotherapy after optimal cytoreductive surgery. After 25 months of being disease free, she had a pelvic recurrence and a good response to chemoradiotherapy.

Conclusions: Optimal cytoreductive surgery and chemotherapy may be the best treatment in MMMT but more discussion and experiences are needed regarding the effectiveness of radiotherapy.

Keywords: Chemoradiotherapy; Chemotherapy; Cytoreductive Surgery; Mixed Tumor, Mullerian; Ovary.

Publication types

Case Reports